Table 2.

Schedule of events

Visits	Baseline day 1	Baseline day 2	Month 3a ± 21 days	Month 6b  ± 21 days	Month 12  ± 21 days
Informed consent	X
Demographic information	X
Medical and surgical history	X
Inclusion exclusion	X
Vital signs	X	X	X	X	X
Physical exam	Xc	Xc	X	X	X
Pregnancy testd	X		X	X	X
10 Meter walk	X
100 m timed	X	X	X	X	X
NSAD	X	X	X	X	X
4 stair climb	X	X	X	X	X
Timed Up and Go (TUG)	X	X	X	X	X
Handheld dynamometry	X	X	X	X	X
Performance Upper Limb PUL 2.0	X	X	X	X	X
9 hole peg test	X	X	X	X	X
Spirometry	X	X	X	X	X
Concomitant meds	X	X	X	X	X
Domain delta questionnaire		X	X	X	X
Patient reported outcome measures	Xc	Xc	X	X	X
Urine biomarkers		X		X	X
Blood biomarkers		X	X	X	X
Prior muscle biopsy acquired (if performed)	X
Review adverse events		X	X	X	X

^aFor individuals with SGCA-G pathogenic variants

^bn/a to DNAJB6/ LGMDD1cohort

^cAssessment can occur on baseline day 1 or baseline day 2

^dPregnancy test for women of childbearing potential